Nov 7 (Reuters) - A U.S. unit of British drug company BTG
Plc pleaded guilty on Monday to improperly marketing its
embolic device LC Bead, and will pay about $36 million to
resolve its criminal and civil liability, the U.S. Department of
Justice said.
Read more
No comments:
Post a Comment